A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Medical device makers are scrambling to develop and sell advanced angioplasty balloons to treat peripheral ...
A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Startup Shockwave Medical expects that its Lithoplasty balloon catheters will emerge as a pretreatment for ...
Shockwave owns US Patent No. 8,956,371 (the “’371 patent”), which is directed to the treatment of atherosclerosis through intravascular lithotripsy. The claimed device is for a “typical over-the-wire ...
The Federal Circuit recently issued a precedential decision in Shockwave Med., Inc. v. Cardiovascular Sys., Inc. (CSI), affirming-in-part and reversing-in-part the Patent Trial and Appeal Board’s ...
ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
Please provide your email address to receive an email when new articles are posted on . Shockwave Medical announced the FDA granted marketing clearance to its device designed to treat calcified plaque ...
FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced the company’s key activities at the annual Transcatheter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results